Clinical Trial Update: Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of EC-18 following oral administration in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• EC-18

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Chemotherapy-Induced Neutropenia | Phase 1 | Status: COMPLETED